Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Get Free Trial
Send Info
On The Fly
Biotech Alert: Searches spiking for these stocks today » 11:16
09/15/23
09/15
11:16
09/15/23
11:16
RNA

Avidity Biosciences

$7.22 /

-0.035 (-0.48%)

, RCKT

Rocket Pharmaceuticals

$24.00 /

-0.08 (-0.33%)

, HOTH

Hoth Therapeutics

$1.94 /

+0.17 (+9.60%)

, CDXS

Codexis

$2.03 /

-0.075 (-3.56%)

, GERN

Geron

$2.25 /

-0.06 (-2.60%)

, NBIX

Neurocrine

$112.54 /

-1.2 (-1.06%)

, AXLA

Axcella Health

$1.01 /

-0.18 (-15.13%)

, MRNA

Moderna

$113.04 /

+0.25 (+0.22%)

, NAVB

Navidea

/

+

These names in the…

Open Full Text

Over a month ago
Hot Stocks
Avidity Biosciences' AOC 1044 granted FDA Orphan Drug designation in DMD » 09:04
08/15/23
08/15
09:04
08/15/23
09:04
RNA

Avidity Biosciences

$8.78 /

-0.075 (-0.85%)

Avidity Biosciences…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Hot Stocks
Avidity Biosciences granted FDA Orphan Drug Designation in DMD » 18:06
08/10/23
08/10
18:06
08/10/23
18:06
RNA

Avidity Biosciences

$8.96 /

-0.395 (-4.22%)

Avidity Biosciences'…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Recommendations
Avidity Biosciences price target lowered to $23 from $27 at Chardan » 05:08
08/09/23
08/09
05:08
08/09/23
05:08
RNA

Avidity Biosciences

$8.93 /

+0.1 (+1.13%)

Chardan lowered the…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Earnings
Avidity Biosciences reports Q2 EPS (66c), consensus (80c) » 16:26
08/08/23
08/08
16:26
08/08/23
16:26
RNA

Avidity Biosciences

$8.93 /

+0.1 (+1.13%)

Reports Q2 revenue $2.3M,…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Over a quarter ago
On The Fly
Biotech Alert: Searches spiking for these stocks today » 10:54
05/25/23
05/25
10:54
05/25/23
10:54
KRYS

Krystal Biotech

$117.51 /

-1.31 (-1.10%)

, BPMC

Blueprint Medicines

$55.95 /

-2.01 (-3.47%)

, RNA

Avidity Biosciences

$10.98 /

-0.315 (-2.79%)

, ACHV

Achieve Life Sciences

$6.03 /

+0.02 (+0.33%)

, OTLK

Outlook Therapeutics

$1.46 /

-0.04 (-2.68%)

These names in the…

Open Full Text

Upgrade
Avidity Biosciences upgraded to Outperform from In Line at Evercore ISI » 06:46
05/22/23
05/22
06:46
05/22/23
06:46
RNA

Avidity Biosciences

$10.82 /

+0.115 (+1.07%)

Evercore ISI analyst Josh…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Hot Stocks
Avidity Biosciences: FDA eases partial clinical hold on AOC 1001 » 07:03
05/17/23
05/17
07:03
05/17/23
07:03
RNA

Avidity Biosciences

$10.96 /

-0.29 (-2.58%)

Avidity Biosciences…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Recommendations
Avidity Biosciences price target lowered to $50 from $55 at Wells Fargo » 06:39
05/11/23
05/11
06:39
05/11/23
06:39
RNA

Avidity Biosciences

$11.54 /

+ (+0.00%)

Wells Fargo analyst Jim…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Earnings
Avidity Biosciences reports Q1 EPS (74c), consensus (85c) » 16:23
05/09/23
05/09
16:23
05/09/23
16:23
RNA

Avidity Biosciences

$11.54 /

+0.42 (+3.78%)

Reports Q1 revenue…

Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Join Now

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.